sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> next generation sequencing ngs market

report

Next-Generation Sequencing (NGS) Market, by Products and Services (Sample Preparation, Sequencing, Data Management and Analysis, Systems and Instruments), Technologies (ION Semiconductor Sequencing, Pyrosequencing, Sequencing by Ligation, Sequencing by Synthesis, Single-Molecule Real-Time Sequencing), End-users (Academic Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC190 November 2016 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the next-generation sequencing (NGS) market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the next-generation sequencing (NGS) market. The scope of this report covers the next-generation sequencing (NGS) market by its major segments, which include the products & services, technologies, end-users, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • Thorough understanding of the dynamics influencing the various segments of this market
  • Detailed analysis of the regulatory environment impacting the growth of this market
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Rapid increase in the healthcare spending is improving access to the quality healthcare and new diagnostic technologies. This is one of the major driving factors for the global next-generation sequencing (NGS) market.
  • Rising incidences of the diseases like cancer and applications of the next-generation sequencing technologies as companion diagnostics for cancer treatment and management are also expected to drive this market during the forecast period.
  • Rapidly aging population which is more susceptible to chronic diseases is also attributed to the rising demand for the NGS market in the next few years.
  • However, the high cost of procedures and reimbursement issues are likely to restrain the growth of this market.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s next-generation sequencing (NGS) market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the next-generation sequencing (NGS) market by the following segments:

  • Next-Generation Sequencing (NGS) Market, by Products & Services
    • Services
      • Sample Preparation
      • Sequencing
      • Data Management and Analysis
    • Systems and Instruments
  • Next-Generation Sequencing (NGS) Market, by Technologies
    • ION Semiconductor Sequencing
    • Pyrosequencing
    • Sequencing by Ligation (SBL)
    • Sequencing by Synthesis (SBS)
    • Single-molecule Real-time Sequencing (SMRT)
    • Other Technologies
  • Next-Generation Sequencing (NGS) Market, by End-users
    • Academic Research Institutes
    • Hospitals & Clinics
    • Pharmaceutical & Biotechnology Companies
    • Other End-users

KEY MARKET PLAYERS

Key players in the next-generation sequencing (NGS) market include:

  • Agilent Technologies, Inc.
  • Beijing Genomics Institute
  • Eurofins Scientific
  • Gatc Biotech AG
  • Illumina, Inc.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies, Ltd.
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Next-Generation Sequencing (NGS) Market

TRENDING RELATED REPORT

Stem Cell Therapy Market, by Treatments (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Applications (Oncology, Eye Diseases, Central Nervous System Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Immune System Disorders), End-users (Hospitals, Ambulatory Surgical Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definition
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Ecosystem Analysis
  5. NEXT-GENERATION SEQUENCING MARKET, BY PRODUCTS AND SERVICES
    1. Segment Share
    2. By Products and Services
      1. Services
        1. Sample Preparation
        2. Sequencing
        3. Data Management and Analysis
      2. Systems and Instruments
  6. NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGIES
    1. Segment Share
    2. By Technologies
      1. ION Semiconductor Sequencing
      2. Pyrosequencing
      3. Sequencing by Ligation (SBL)
      4. Sequencing by Synthesis (SBS)
      5. Single-molecule Real-time Sequencing (SMRT)
      6. Other Technologies
  7. NEXT-GENERATION SEQUENCING MARKET, BY END-USERS
    1. Segment Share
    2. By End-users
      1. Academic Research Institutes
      2. Hospitals & Clinics
      3. Pharmaceutical & Biotechnology Companies
      4. Other End-users
  8. NEXT-GENERATION SEQUENCING MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Products and Services
      3. By Technologies
      4. By End-users
    2. Europe
      1. By Regions
        1. Germany
        2. U.K.
        3. Rest of Europe
      2. By Products and Services
      3. By Technologies
      4. By End-users
    3. Asia-Pacific
      1. By Regions
        1. China
        2. Japan
        3. India
        4. Rest of Asia-Pacific
      2. By Products and Services
      3. By Technologies
      4. By End-users
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Products and Services
      3. By Technologies
      4. By End-users
  9. COMPETITIVE LANDSCAPE
  10. KEY MARKET PLAYERS
    1. Agilent Technologies, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Beijing Genomics Institute
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Eurofins Scientific
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Gatc Biotech AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Illumina, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Macrogen Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Oxford Nanopore Technologies, Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Pacific Biosciences of California, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. Perkinelmer, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Qiagen N.V.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    11. Thermo Fisher Scientific, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us